(Q48918674)

16 February 2018

title

Vasopressin response to dehydration in Alzheimer's disease. (English)

1 reference

16 February 2018

0 references

0 references

Albert SG

1

1 reference

16 February 2018

Nakra BR

series ordinal

2

1 reference

16 February 2018

Grossberg GT

series ordinal

3

1 reference

16 February 2018

Caminal ER

series ordinal

4

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 September 1989

1 reference

16 February 2018

Journal of the American Geriatrics Society

published in

1 reference

16 February 2018

volume

37

1 reference

16 February 2018

issue

9

1 reference

16 February 2018

page(s)

843-847

1 reference

16 February 2018

NIH Conference. Alzheimer's disease and Down's syndrome: new insights

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

The biologic clock: the mitochondria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

CSF vasopressin concentration is reduced in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and beta-endorphin in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

CSF and plasma vasopressin concentrations in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

Desamino-D-arginine-vasopressin (DDAVP) in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

The Response of Arginine Vasopressin to Intravenous Ethanol and Hypertonic Saline in Man: The Impact of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

Reduced thirst after water deprivation in healthy elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

Alterations in vasopressin regulation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

Screening for organic mental syndromes in the medically ill

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

Abnormalities of thirst regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1989.TB02264.X

10.1111/J.1532-5415.1989.TB02264.X

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018